# Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers

> **NCT01684605** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 31 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** NESP 60μg
- **DRUG:** CKD-11101 60μg

## Key facts

- **NCT ID:** NCT01684605
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-12
- **Primary completion:** 2012-11-13
- **Final completion:** 2013-01-03
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01684605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01684605, "Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01684605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*